Remove 2021 Remove Communication Remove Insurance Coverage and Processing
article thumbnail

NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the IRA ICR Forms

Putting Patients First Blog

Other members include health-related associations and nonprofit organizations including the provider, research, and family caregiver communities; and businesses and organizations representing biopharmaceuticals, devices, diagnostics, generics, and payers.

article thumbnail

NHC’s comments in response to the 2025 Notice of Benefit and Payment Parameters (NBPP)

Putting Patients First Blog

Making available more specific information about total costs and coverage will ensure that all consumers have comprehensive information to help them make smart health care decisions. These resources should aim to clarify insurance terms and concepts, aiding consumers in navigating the complexities of selecting a health plan.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. To overcome manufacturing issues, in December 2021, Novo Nordisk announced its plans to build three new manufacturing facilities. compared to a 5.1% Free Report.

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. To overcome manufacturing issues, in December 2021, Novo Nordisk announced its plans to build three new manufacturing facilities. compared to a 5.1% Free Report.

article thumbnail

Release of International Book: “DTx An Opportunity for Italy and Beyond”

pharmaphorum

Milan, Italy | October 5, 2021 – Originally published in January 2021 for Italian audiences, the international, updated version of “DTx: An Opportunity for Italy and Beyond” is now available in English. Contact: Antonietta Pannella, Marketing & Communications Director, Healthware Group.

article thumbnail

State of Well-Being 2023-2024

The Happy PharmD

Since 2021, pharmacy-related organizations have been addressing stress and burnout in the profession. Or perhaps it’s the constant back-and-forth with insurance companies over coverage? The stress experienced by community pharmacists compared to those in other settings is well-documented and has been a longstanding issue.

article thumbnail

MTHFR, Hashimoto’s and Nutrients

The Thyroid Pharmacist

4] One of the key things to note is that this gene variation also prevents people from properly methylating, which is one of the body’s key detox processes that helps them get rid of toxins. However, some may be concerned with this genetic information getting reported on insurance or to employers.